Pennsylvania children’s hospital reaffirms routine shots as federal guidance shifts
Penn State Health Golisano Children’s Hospital is reiterating support for routine childhood immunizations amid recent changes to the federal vaccine schedule that move several shots from universal recommendations to risk-based or shared clinical decision-making categories. The hospital’s stance comes as national health authorities recalibrate how vaccines are classified without changing the underlying scientific evidence on their safety and effectiveness.
“Vaccines protect children by safely preparing the immune system to prevent severe illness before exposure occurs,” said Sarah Iriana, interim vice president of Penn State Health Children’s Services and interim pediatrician-in-chief of Penn State Health Golisano Children’s Hospital. “Without widespread immunization, babies and children face increased risk of hospitalization, long-term complications and, in some cases, death. Declining immunization rates nationally have already contributed to rising cases of flu, measles, whooping cough and other preventable diseases. Our commitment remains clear: protecting children’s health through compassionate, evidence-based care and clear, reliable information.”
What changed in the national schedule
Federal health authorities announced a three-track framework for the child and adolescent schedule: vaccines recommended for all children; vaccines recommended for certain high‑risk groups or populations; and vaccines based on shared clinical decision‑making between families and clinicians. The new structure is intended to distinguish between shots that are universally needed and those where timing or indication may vary by age, health status, or local epidemiology.
| Schedule category | Examples of vaccines in 2026 framework |
|---|---|
| Recommended for all children | Measles, mumps, rubella (MMR); polio (IPV); diphtheria, tetanus, pertussis (DTaP/Tdap); Haemophilus influenzae type b (Hib); pneumococcal; human papillomavirus (HPV); varicella. These remain core routine childhood vaccines given on a standardized timeline in primary care. |
| Shared clinical decision‑making | Rotavirus; COVID‑19; influenza; meningococcal; hepatitis A; hepatitis B. In these cases, clinicians are expected to review individual risk factors, local disease patterns, and family preferences before confirming the recommendation. |
| Recommended for certain high‑risk groups or populations | Applies when underlying conditions, exposure risks, or settings elevate disease risk; providers consider medical indications summarized in the schedule’s table of conditions, such as chronic lung disease, immunocompromise, or residence in congregate settings. |
While the categories have shifted, public‑health officials emphasize that vaccines moved into shared decision‑making or high‑risk tracks were not “downgraded” for safety. Instead, the change is framed as aligning recommendations more closely with individual and community risk profiles.
What stays the same: coverage, access and state rules
For families, the most immediate question is whether these federal shifts will affect cost or school participation. Health‑policy experts stress that the core financing and regulatory architecture around childhood vaccination remains intact.
- Insurance coverage: All vaccines on the federal child and adolescent schedule remain covered without cost‑sharing under Affordable Care Act plans and federal programs such as Medicaid and the Children’s Health Insurance Program, even when placed in risk‑based or shared decision‑making categories.
- Vaccines for Children (VFC): Federally purchased vaccines continue to be provided at no cost to eligible children through VFC providers nationwide, supporting access regardless of ability to pay. Hospitals and pediatric practices rely on this program to maintain high coverage in low‑income communities.
- School entry requirements: States set their own immunization requirements for childcare and K‑12 enrollment, typically acting on recommendations from the Centers for Disease Control and Prevention but codifying them through state health and education regulations. The recent federal changes do not automatically alter state laws or policies; any adjustments in Pennsylvania would require state‑level rulemaking or legislation.
Why institutional clarity matters right now
Hospital leaders say their decision to restate support for routine vaccination is as much about governance and trust as it is about clinical practice. When federal guidance becomes more segmented, local institutions often become the front line for explaining what has – and has not – changed.
- Public‑health signal: Formal reclassification of multiple vaccines can create uncertainty for parents and providers and may affect uptake if families perceive “optional” status rather than evidence‑based risk assessment. Institutional statements help clarify that many vaccines moved into shared decision‑making remain strongly recommended for most children.
- Disease control stakes: Childhood vaccination is a population‑level intervention; sustained coverage interrupts transmission of measles, pertussis, and other pathogens that rapidly exploit immunity gaps. Even modest declines in uptake can force health departments and school districts to divert resources to outbreak response and exclusion policies.
- Trust and communication: Federal communications have cited declining trust and falling immunization rates in recent years, heightening the need for clear, consistent messages from health systems. Hospitals, pediatric practices, and state health agencies are now being asked to explain more nuanced guidance without feeding politicization or misinformation.
Operational considerations for health systems and pediatric practices
Behind the scenes, the new framework also has operational implications for how care teams schedule visits, document consent, and report data to public‑health authorities.
- Workflow and counseling: Revisions increase the time and documentation needed for shared decision‑making discussions, especially for influenza and other seasonally timed vaccines. Clinicians must integrate risk‑based questions into already compressed well‑child visits while maintaining clear, noncoercive communication.
- Equity and access: Families facing language, transportation, or insurance barriers are more likely to miss multi‑dose or later‑age vaccines. Programs like VFC help, but disparities persist and require proactive outreach, reminder systems, and partnerships with schools and community organizations to avoid widening gaps in protection.
- Data systems: Monitoring coverage across “universal,” “high‑risk,” and “shared decision‑making” categories will require immunization registry updates and careful interpretation of trends. Public‑health agencies will need to distinguish between true hesitancy, access barriers, and legitimate clinical deferrals when tracking uptake.
Pennsylvania context and institutional positions
The hospital’s statement aligns with positions long held by major professional societies that endorse routine childhood immunization schedules as a proven public‑health safeguard. In Pennsylvania, those schedules interact with state immunization regulations that govern entry to childcare centers and public schools, giving hospital guidance practical implications for families navigating enrollment paperwork as well as medical decisions.
Penn State Health Golisano Children’s Hospital reports it will continue to follow evidence‑based schedules used in pediatric practice and encourages families to discuss vaccine decisions with their child’s clinician, particularly where the new framework calls for shared decision‑making. Administrators say they view the changes as an opportunity to strengthen long‑term relationships with families and to coordinate closely with state and local health departments on consistent messaging.
Key reference points for families and providers
For families and frontline clinicians, the most authoritative reference remains the child and adolescent immunization schedule issued by the national public‑health agency that oversees vaccine recommendations in the United States. That schedule, published annually in coordination with expert advisory committees, serves as the primary regulatory framework that insurers, state health departments, and school systems use when setting their own requirements and benefits.
- For the current national schedule framework and age‑by‑age recommendations, see the official child and adolescent immunization schedule maintained by the Centers for Disease Control and Prevention.
- For no‑cost vaccine access pathways, families can ask their pediatrician whether they participate in the Vaccines for Children program, which supplies federally purchased vaccines to eligible children at no charge.
